For example, lithium treatment, used in patients affected by bipolar disorder and likely exerting neuroprotective effects [121,122], changes the expression levels of several genes in astrocytes, including Krüppel-like factor 4 (KLF4) and PARK2 co-regulated (PARKRG) [123]. Here, KLF4 is linked to bipolar disorder.